Nebivolol Hydrochloride NDC 29300-375

NDC codes

FDA NDC Directory

Product NDC (as listed)29300-375Labeler and product segments. Claims need a package NDC.

Product NDC at billing width29300-0375Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
29300-375-05	29300037505	500 TABLET in 1 BOTTLE (29300-375-05)Marketed from Apr 4, 2022
29300-375-13	29300037513	30 TABLET in 1 BOTTLE (29300-375-13)Marketed from Apr 4, 2022
29300-375-19	29300037519	90 TABLET in 1 BOTTLE (29300-375-19)Marketed from Apr 4, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nebivolol Hydrochloride
Generic name (nonproprietary): nebivolol hydrochloride
Active ingredients: Nebivolol hydrochloride — 2.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Unichem Pharmaceuticals (USA), Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213830
Marketing start: Apr 4, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 29300-375_1a80b28a-62f6-443e-8e8d-fc89b74be5eaSPL ID 1a80b28a-62f6-443e-8e8d-fc89b74be5eaSPL set ID b1762bbb-b5be-48a7-8101-bb736f28845aRxCUI 387013, 751612, 751618, 827073UNII JGS34J7L9IUPC 0329300375138, 0329300376135, 0329300377132, 0329300378139
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N429300037505 followed by a unit qualifier and the quantity

Package 29300-0375-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 11, 2023.

Indications (excerpt from the label)

Nebivolol is a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) 1.1 Hypertension Nebivolol tablets are indicated for the treatment of hypertension, to lower blood pressure [see Clinical Studies ( 14.1 )]. Nebivolol tablets may be used alone or in combination with other antihypertensive agents [see Drug Interactions ( 7 )]. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213830

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213830
Product	Strength	Form · route	Labeler	Product NDC
Nebivolol Hydrochloride	Nebivolol hydrochloride 10 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-377
Nebivolol Hydrochloride	Nebivolol hydrochloride 5 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-376
Nebivolol Hydrochloride	Nebivolol hydrochloride 20 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-378